Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1661-4917
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy ; day:15 ; month:11 ; year:2018 ; pages:1-10
Archivum immunologiae et therapiae experimentalis ; (15.11.2018), 1-10
- Creator
-
Urbanowicz, Arkadiusz
Zagożdżon, Radosław
Ciszek, Michał
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00005-018-0532-8
- URN
-
urn:nbn:de:101:1-2018121513505478996013
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Urbanowicz, Arkadiusz
- Zagożdżon, Radosław
- Ciszek, Michał
- SpringerLink (Online service)
Other Objects (12)
Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling
Influence of the hepatitis C genotype on the antiviral immune response
Nuclear PCGF3 inhibits the antiviral immune response by suppressing the interferon-stimulated gene
Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
Viral recognition and the antiviral interferon response
Interferon regulatory factors 1 and 4 in T cell mediated immune modulation
Antiviral drugs against hepatitis C virus
Transcriptome Analyses Implicate Endogenous Retroviruses Involved in the Host Antiviral Immune System through the Interferon Pathway
RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C
Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy
Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling
Influence of the hepatitis C genotype on the antiviral immune response
Nuclear PCGF3 inhibits the antiviral immune response by suppressing the interferon-stimulated gene
Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
Viral recognition and the antiviral interferon response
Interferon regulatory factors 1 and 4 in T cell mediated immune modulation
Antiviral drugs against hepatitis C virus
Transcriptome Analyses Implicate Endogenous Retroviruses Involved in the Host Antiviral Immune System through the Interferon Pathway
RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C
Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy
Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling
Influence of the hepatitis C genotype on the antiviral immune response
Nuclear PCGF3 inhibits the antiviral immune response by suppressing the interferon-stimulated gene
Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
Viral recognition and the antiviral interferon response
Interferon regulatory factors 1 and 4 in T cell mediated immune modulation
Antiviral drugs against hepatitis C virus
Transcriptome Analyses Implicate Endogenous Retroviruses Involved in the Host Antiviral Immune System through the Interferon Pathway
RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C